US Patent Issued to BEIJING TIDE PHARMACEUTICAL on Aug. 26 for "Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,118, issued on Aug. 26, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof" was invented by Yanping Zhao (Beijing), Hongjun Wang (Beijing), Gong Li (Beijing), Yuanyuan Jiang (Beijing), Xiang Li (Beijing), Bin Liu (Beijing), Kai Liu (Beijing), Weiting Zhong (Beijing), Fajie Li (Beijing), Jing Zhao (Beijing), Jianmei Pang (Beijing) and Liying Zhou (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Rho-associated protein kinase (ROCK) inhibitor represented by formula (I), a pharmaceutical composition comprising same, and a use there...